Correspondence on: Efficacy and safety of subthreshold micropulse laser compared with threshold conventional laser in central serous chorioretinopathy

Lihteh Wu^{1

2}, José A Roca³

Affiliations

¹ Asociados de Macula Vitreo y Retina de Costa Rica, Primer Piso Torre Mercedes Paseo Colón, San José, Costa Rica. LW65@cornell.edu.
² Illinois Eye and Ear Infirmary, Department of Ophthalmology, University of Illinois School of Medicine, Chicago, IL, USA. LW65@cornell.edu.
³ Oftalmologos Contreras, Lima, Perú.

Comment

Lihteh Wu et al. Eye (Lond). 2021 Nov.

. 2021 Nov;35(11):3161-3162.

doi: 10.1038/s41433-020-01253-8. Epub 2020 Oct 29.

Lihteh Wu^{1

2}, José A Roca³

¹ Asociados de Macula Vitreo y Retina de Costa Rica, Primer Piso Torre Mercedes Paseo Colón, San José, Costa Rica. LW65@cornell.edu.
² Illinois Eye and Ear Infirmary, Department of Ophthalmology, University of Illinois School of Medicine, Chicago, IL, USA. LW65@cornell.edu.
³ Oftalmologos Contreras, Lima, Perú.

No abstract available

Conflict of interest statement

The authors declare that they have no conflict of interest.

Efficacy and safety of subthreshold micropulse laser compared with threshold conventional laser in central serous chorioretinopathy.
Sun Z, Huang Y, Nie C, Wang Z, Pei J, Lin B, Zhou R, Zhang J, Chong V, Liu X. Sun Z, et al. Eye (Lond). 2020 Sep;34(9):1592-1599. doi: 10.1038/s41433-019-0692-8. Epub 2019 Nov 29. Eye (Lond). 2020. PMID: 31784704 Free PMC article. Clinical Trial.

1. Sun Z, Huang Y, Nie C, Wang Z, Pei J, Lin B, et al. Efficacy and safety of subthreshold micropulse laser compared with threshold conventional laser in central serous chorioretinopathy. Eye. 2019;34:1592–9. doi: 10.1038/s41433-019-0692-8. - DOI - PMC - PubMed
1. Gilbert CM, Owens SL, Smith PD, Fine SL. Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol. 1984;68:815–20. doi: 10.1136/bjo.68.11.815. - DOI - PMC - PubMed
1. Klein ML, Van Buskirk EM, Friedman E, Gragoudas E, Chandra S. Experience with nontreatment of central serous choroidopathy. Arch Ophthalmol. 1974;91:247–50. doi: 10.1001/archopht.1974.03900060257001. - DOI - PubMed
1. Daruich A, Matet A, Marchionno L, De Azevedo JD, Ambresin A, Mantel I, et al. Acute central serous chorioretinopathy: factors influencing episode duration. Retina. 2017;37:1905–15. doi: 10.1097/IAE.0000000000001443. - DOI - PMC - PubMed
1. Wong R, Chopdar A, Brown M. Five to 15 year follow-up of resolved idiopathic central serous chorioretinopathy. Eye. 2004;18:262–8. doi: 10.1038/sj.eye.6700637. - DOI - PubMed